NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
+8.83%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$824M
AUM Growth
-$219M
(-21%)
Cap. Flow
-$223M
Cap. Flow
% of AUM
-27.02%
Top 10 Holdings %
Top 10 Hldgs %
50.4%
Holding
132
New
16
Increased
19
Reduced
47
Closed
17
Top Buys
| 1 |
The Bancorp
TBBK
|
$13.3M |
| 2 |
Lyra Therapeutics
LYRA
|
$7.14M |
| 3 |
Amneal Pharmaceuticals
AMRX
|
$5.11M |
| 4 |
Cytokinetics
CYTK
|
$4.87M |
| 5 |
InspireMD
NSPR
|
$4.67M |
Top Sells
| 1 |
TA
TravelCenters of America LLC
TA
|
$51.7M |
| 2 |
APEN
Apollo Endosurgery, Inc.
APEN
|
$45.4M |
| 3 |
iShares Russell 2000 ETF
IWM
|
$25.2M |
| 4 |
Travel + Leisure Co
TNL
|
$24.4M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
$13.7M |
Sector Composition
| 1 | Healthcare | 51.51% |
| 2 | Financials | 11.55% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Communication Services | 8.45% |
| 5 | Industrials | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACER
76
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
| $1.05M | 0.1% |
1,136,416
-66,710
| -6% | -$61.6K |
|
77
SPAR Group
SGRP
$28.2M
| $955K | 0.09% |
758,032
+61,454
| +9% | +$77.4K |
|
|
78
Travel + Leisure Co
TNL
$4.08B
| $928K | 0.09% |
23,016
-605,463
| -96% | -$24.4M |
|
79
Elicio Therapeutics
ELTX
$188M
| $902K | 0.09% |
94,939
-3,335
| -3% | -$31.7K |
|
|
DHC
80
Diversified Healthcare Trust
DHC
$995M
| $890K | 0.09% |
395,613
-4,993,024
| -93% | -$11.2M |
|
81
SCYNEXIS
SCYX
$37.3M
| $885K | 0.09% |
300,000
| – | – |
|
82
Unicycive Therapeutics
UNCY
$77M
| $829K | 0.08% |
64,742
| – | – |
|
83
Taysha Gene Therapies
TSHA
$917M
| $827K | 0.08% |
1,251,139
-471,261
| -27% | -$312K |
|
84
Cogent Biosciences
COGT
$1.82B
| $759K | 0.07% |
+64,132
| New | +$759K |
|
|
BGRY
85
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $705K | 0.07% |
+500,000
| New | +$705K |
|
|
APTO
86
DELISTED
Aptose Biosciences, Inc.
APTO
| $679K | 0.07% |
4,874
-6,190
| -56% | -$862K |
|
87
Carvana
CVNA
$50.9B
| $648K | 0.06% |
+25,000
| New | +$648K |
|
88
Sensus Healthcare
SRTS
$53.1M
| $583K | 0.06% |
185,048
| – | – |
|
89
Transact Technologies
TACT
$45.7M
| $354K | 0.03% |
39,500
-21,289
| -35% | -$191K |
|
90
Exagen
XGN
$213M
| $353K | 0.03% |
121,894
-10,719
| -8% | -$31.1K |
|
|
AKU
91
DELISTED
Akumin Inc. Common Stock (DE)
AKU
| $340K | 0.03% |
1,886,856
| – | – |
|
|
LADR
92
Ladder Capital
LADR
$1.51B
| $294K | 0.03% |
+27,073
| New | +$294K |
|
93
Journey Medical
DERM
$184M
| $284K | 0.03% |
178,706
-33,651
| -16% | -$53.5K |
|
94
Lucid Diagnostics
LUCD
$140M
| $277K | 0.03% |
199,074
-62,590
| -24% | -$87K |
|
|
EAR
95
DELISTED
Eargo, Inc. Common Stock
EAR
| $266K | 0.03% |
54,002
| – | – |
|
|
BMTX
96
DELISTED
BM Technologies, Inc.
BMTX
| $236K | 0.02% |
79,212
| – | – |
|
97
Avalo Therapeutics
AVTX
$153M
| $198K | 0.02% |
2,318
-1,052
| -31% | -$89.7K |
|
98
Rafael Holdings
RFL
$50.5M
| $152K | 0.01% |
73,695
| – | – |
|
|
EBET
99
DELISTED
EBET, INC. Common Stock
EBET
| $126K | 0.01% |
35,514
| – | – |
|
|
NOGNW
100
DELISTED
Nogin, Inc. Warrant
NOGNW
| $112K | 0.01% |
+330,000
| New | +$112K |
|